CMG제약

058820KOSDAQ의약품 제조업

43.5 / 100

Reference Date: 2026-06-10

Financial Score18.0 / 40

News Sentiment12.5 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 33.4% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

CMG Pharmaceutical is a core subsidiary of Chabiotech Group, specializing in the R&D, production, and sales of pharmaceuticals and health functional foods. The company focuses on developing improved new drugs using its proprietary STARFILM Technology, which enables unique taste and stability in oral disintegrating films (ODF). It is expanding into high-growth sectors such as oncology, anti-aging, ophthalmology, and maternal and baby care, while also operating an animal pharmaceutical business through its subsidiaries to enhance shareholder value.

Number of Employees

206people

Average Salary

62.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.934.0Point

PBR

0.80Industry Average 0.894.0Point

In line with industry avg

ROE

-5.15Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

0.37Industry Average 12.438.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼264.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -0.1% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 1,087Won52-week high 2,29552-week low 1,087

1-month return0.0Point

1m -33.44% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral분기보고서 (2026.03)2026-05-14